Quick wins for a faster PC:
Clear out junk files and repair common Windows errorsFree Scan →Scan for outdated or missing drivers - takes under a minuteDriver Scan →R&D spending shows that a company is funding research and development; it does not show whether that work produced products people buy or processes the business puts to use. To judge whether the spending is producing useful innovation, follow the evidence from resources, to significant changes brought to market, to sales or other business outcomes—and allow time for customers to adopt new products.
Start with what counts as innovation
Under the OECD/Eurostat Oslo Manual 2018, a business innovation is a product or business process that differs significantly from the company’s previous products or processes and has been introduced on the market or brought into use. A project, patent, launch announcement, or rebrand alone does not meet that test.
That distinction keeps the analysis focused on realized changes. For products, look for offerings that are meaningfully new or improved and actually sold. For process innovation, look for a changed way of operating that has been put into use.
Read R&D as an input, not a scorecard
R&D expense, R&D as a share of sales, staffing, and project descriptions can show the scale and direction of a company’s effort. They cannot establish that the effort generated a successful innovation. The Oslo Manual defines R&D using five criteria: it is novel, creative, uncertain in outcome, systematic, and transferable or reproducible. Applied research has a practical aim; experimental development seeks to produce or improve products or processes.
#1 Best Overall
R&D is also only one part of innovation activity. The Oslo Manual includes related work such as engineering, design, software, marketing, training, tangible investment, intellectual property, and innovation management. The OECD put it plainly in its 2025 report: “Innovation activity is not restricted to R&D.” A company’s R&D line may therefore understate or fail to describe its wider innovation effort. When comparing firms, check whether their reported figures cover R&D alone or broader innovation costs.
Trace the evidence from spending to business value
Review a company over multiple years, preferably by business segment or product family where it reports enough detail. Use the stages below to distinguish activity from results.
Rank #2
- Ideal for Gifting
- Ideal for a bookworm
- Compact for travelling
| Stage | Evidence to examine | What it tells you—and what it does not |
|---|---|---|
| Input | R&D expense, R&D intensity (R&D relative to sales), reported staff or project activity, and any broader innovation spending | Shows resources devoted to innovation. It does not prove that a product or process resulted, or that the result was commercially useful. |
| Output | Products significantly new or improved compared with the company’s prior offerings, or processes brought into use | Shows realized innovation under the OECD/Eurostat definition. A launch count without evidence of meaningful change and market introduction is weaker evidence. |
| Market traction | Sales attributed to product innovations, with products new to the market separated from those new only to the firm where disclosed | Shows whether new or improved products are contributing to sales. It is an estimated contribution, not proof that R&D caused those sales. |
| Economic value | Innovation-related profit margin, market share, sales growth, or productivity and cost effects for process changes | Helps assess commercial or operating value, but these outcomes can also reflect factors beyond innovation. |
| Portfolio learning | Work that was abandoned, postponed, delayed, or followed by later improvements | Provides context for a portfolio: innovation work can build knowledge without producing an innovation within the period being reviewed. |
Use innovation sales share carefully
The Oslo Manual recommends measuring the share of total sales in a reference year that respondents estimate is due to product innovations. Where the company provides the breakdown, distinguish among products introduced during the period that were new to the market, products new only to the firm, and unchanged or only marginally modified products. Collected as specified, these categories sum to 100% of sales.
Read the definition and time window behind any company figure. A reported share based on products new only to that company does not mean the same thing as a share from products new to the market. And sales share is an output measure: it indicates market contribution, not the amount of profit earned or the return on a particular R&D project.
Give consumer products time to find customers
A product introduced late in a reporting period may have little time to generate sales. Consumer adoption can also be gradual. The OECD/Eurostat manual says innovation-sales questions are likely, on average, to produce better results with a three-year observation period than with a one-year period. That is a measurement recommendation, not a rule that every product needs three years to succeed.
When reviewing results, note launch dates and compare products over a suitable period rather than judging them only by the first year. If companies have different launch calendars, a simple same-year comparison can make one portfolio look weaker merely because its products entered the market later.
Rank #4
Compare companies on like-for-like terms
There is no universal consumer-company R&D productivity ratio or cutoff in the cited guidance that tells an investor how much innovation is “good.” A more useful comparison asks whether the definitions, timing, and business mix are comparable.
- Compare innovation-sales shares using the same definition, including whether “new” means new to the market or only new to the firm.
- Account for time since launch and differences in product adoption cycles.
- Look at margins, market share, sales growth, or relevant process outcomes alongside sales contribution.
- Check R&D intensity and whether each company reports R&D alone or broader innovation costs.
- Compare similar segments or product families where possible; changes in product mix can affect company-wide results.
These measures support a more disciplined assessment, but they do not isolate the effect of R&D. Sales, margins, and market share can change for reasons other than research and development, while innovation impacts may emerge over time or across organizations. Establishing that a particular R&D investment caused a result would require company-specific evidence about projects, launches, suitable comparisons, and other performance drivers.
Best Value
- It can be a gift option
- Comes with secure packaging
- Helpful in various ways
What the evidence can—and cannot—establish
A convincing case for useful innovation combines evidence that meaningful products or processes reached the market or were put into use with signs of sales, economic, or operating contribution over a suitable period. R&D expense alone is evidence of an input; patents or launch counts alone are not evidence of commercial success. Even strong outcomes are indicators of business value rather than proof of a causal return on a specific R&D dollar.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
